Sam Chun Dang Pharm. Co., Ltd (KOSDAQ: A000250)
Health Care · Pharmaceuticals · KR
₩168,700.00
-10.74% today · -8.4% 1Y
Sam Chun Dang Pharm. Co., Ltd (KOSDAQ: A000250) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.85B.
Over the last twelve months the share price has lost 8.4%, trading between 120.00K and 1.23M.
Tweenvest scores Sam Chun Dang Pharm. Co., Ltd across four factors: quality 65/100, value 25/100, dividend 1/100. Its strongest factor is quality.
A000250 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.85B
- Revenue (TTM)
- $161.64M
- P/E
- —
- EPS
- 438.83
- Dividend yield
- 0.03%
- Beta (5Y)
- 1.43
- 52-week high
- ₩1,233,000.00
- 52-week low
- ₩120,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.41M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,190.02 | -3.54% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.56 | -0.94% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.39 | -1.96% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.33 | -0.86% |
Figures last refreshed Aug 18, 2026.